Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
303
-
Total 13F shares, excl. options
-
53.4M
-
Shares change
-
-1.27M
-
Total reported value, excl. options
-
$5.02B
-
Value change
-
-$141M
-
Put/Call ratio
-
1.88
-
Number of buys
-
140
-
Number of sells
-
-166
-
Price
-
$94.03
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2014
368 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q1 2014.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 303 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.4M shares
.
Largest 10 shareholders include FMR LLC (5.78M shares), VANGUARD GROUP INC (2.98M shares), AJO, LP (2.16M shares), BlackRock Fund Advisors (1.98M shares), DEUTSCHE BANK AG\ (1.9M shares), ACADIAN ASSET MANAGEMENT LLC (1.87M shares), BlackRock Institutional Trust Company, N.A. (1.8M shares), LSV ASSET MANAGEMENT (1.74M shares), BlackRock Advisors LLC (1.64M shares), and State Street Corp (1.43M shares).
This table shows the top 303 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.